Company Filing History:
Years Active: 2016-2020
Title: Moshit Lindzen: Innovator in Cancer Treatment
Introduction
Moshit Lindzen is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, Lindzen is recognized for his work in developing methods and compositions that enhance cancer therapies.
Latest Patents
Lindzen's latest patents include groundbreaking advancements in the treatment of cancer. One notable patent is for "Anti amphiregulin antibodies, compositions comprising same and uses thereof." This invention provides a method for determining the suitability of a subject with specific types of cancer, such as ovarian cancer, head and neck cancer, and pancreatic cancer, for treatment with anti-amphiregulin antibodies. The method involves analyzing biological samples to assess the expression levels of amphiregulin, transforming growth factor alpha (TGF-alpha), and heparin-binding epidermal growth factor (HB-EGF).
Another significant patent is for "Anti-HER3 antibodies and uses of same." This invention describes an isolated polypeptide that specifically binds to human HER-3, inhibiting neuregulin binding and consequently reducing cancer cell migration and proliferation. Clones NG83 and NG140 are also provided, which demonstrate strong binding affinity to human HER-3.
Career Highlights
Moshit Lindzen is associated with Yeda Research and Development Co. Ltd., where he continues to push the boundaries of cancer research. His work has been instrumental in developing new therapeutic strategies that target specific cancer pathways, thereby improving treatment outcomes for patients.
Collaborations
Lindzen has collaborated with esteemed colleagues in the field, including Yosef Yarden and Silvia Carvalho. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in cancer treatment.
Conclusion
Moshit Lindzen's contributions to cancer research and treatment through his patented inventions highlight his role as a leading inventor in the field. His innovative approaches have the potential to transform cancer therapies and improve patient outcomes.